Summit Therapeutics (SUMM)

 

Latest News

Summit Therapeutics plc : Grant of Share Options

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

Summit Therapeutics plc : Exercise of Share Options

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS Congress

A statement giving an update on research (e.g. clinical trials)

Four AIM shares for a post-election world

Given UK political uncertainty, former AIM writer of the year Andrew Hore names companies exposed to overseas earnin...

All News

DateHeadlineSource
28-06-17Summit Therapeutics plc : Grant of Share OptionsRNS
28-06-17Summit Therapeutics plc : Exercise of Share OptionsRNS
22-06-17Summit Presents Data from Phase 1 Clinical Programme of Ezutromid at the EPNS CongressRNS
16-06-17Four AIM shares for a post-election worldInteractive Investor
15-06-17Summit Therapeutics to Participate in JMP Securities Life Sciences ConferenceRNS
14-06-17Summit losses fallStockMarketWire
14-06-17Summit Therapeutics plc : 1st Quarter ResultsRNS
13-06-17Summit confirms date of Q1 results announcementStockMarketWire
13-06-17Summit Therapeutics plc : Notice of ResultsRNS
05-06-17Summit highlights benefits of ridinilazole at ASM MicrobeStockMarketWire
05-06-17Summit Presents Positive New Preclinical Data on Novel CDI Antibiotic Ridinilazole at ASM Microbe 2017RNS
23-05-17Summit Announces Key Appointments to Strengthen Research & Development TeamRNS
15-05-17Summit completes PhaseOut DMD enrolmentStockMarketWire
15-05-17Summit Completes Enrolment of PhaseOut DMD, a Phase 2 Clinical Trial of Ezutromid in Patients with DMDRNS
02-05-17Summit Therapeutics plc: Phase 2 CoDIFy Trial Results Published in Lancet Infectious DiseasesRNS
25-04-17Summit Therapeutics plc : Notice of AGMRNS
12-04-17Summit Therapeutics plc : Grant of Share OptionsRNS
10-04-17Summit Therapeutics plc : Exercise of OptionsRNS
31-03-17Summit Therapeutics File US Annual Report on Form 20-FRNS
30-03-17Summit changes registered officeStockMarketWire
30-03-17Summit Therapeutics plc : Change of Registered OfficeRNS
30-03-17Summit Therapeutics to Present at the Needham Healthcare ConferenceRNS
29-03-17Summit Therapeutics Reports 4th Quarter and Year End Financial Results and Operational ProgressRNS
27-03-17Summit schedules FY resultsStockMarketWire
27-03-17Summit to extend PhaseOut DMD clinical trialStockMarketWire
27-03-17Summit Therapeutics plc : Notice of ResultsRNS
27-03-17Summit to Extend Ongoing PhaseOut DMD Clinical Trial of Ezutromid in Patients with DMDRNS
15-03-17Summit Therapeutics to Present at the Oppenheimer 27th Annual Healthcare ConferenceRNS
05-03-17Trends and Targets for 6/03/2017Trends and Targets
28-02-17Summit Therapeutics Recognises Tenth Annual Rare Disease DayRNS
23-02-17Summit Therapeutics plc : Exercise of WarrantsRNS
02-02-17Summit to take part in investor conferencesStockMarketWire
02-02-17Summit Therapeutics to Participate in February Investor ConferencesRNS
01-02-17Summit outlines Phase 3 programme for ridinilazoleStockMarketWire
01-02-17Summit Outline Phase 3 Programme for Novel CDI Antibiotic RidinilazoleRNS
25-01-17Summit Therapeutics plc : Holding(s) in CompanyRNS
19-01-17Summit Therapeutics plc : Exercise of OptionsRNS
18-01-17Summit Appoints Dr David Roblin as Chief Operating Officer and President of Research & DevelopmentRNS
15-12-16Summit Therapeutics plc : 3rd Quarter ResultsRNS
13-12-16Summit Therapeutics plc : Notice of ResultsRNS

RSS feeds

  • Editorial news feed for LSE:SUMM Editorial
  • Regulatory news feed for LSE:SUMM Regulatory